The global artificial urinary sphincter market size is expected to reach USD 853.30 million by 2030, expanding at a CAGR of 7.1% from 2023 to 2030, based on a new report by Grand View Research, Inc. Stress urinary incontinence (SUI) is the most prevalent form of urinary incontinence among women. According to the National Association for Incontinence, SUI affects an estimated 15 million adult women in the U.S. Furthermore, certain neurological conditions, such as multiple sclerosis, Parkinson's disease, or spinal cord injuries, can affect the nerves that control bladder function. When these nerves are damaged or impaired, it can lead to SUI. Thus, an increasing number of women patients suffering from SUI is projected to fuel demand for AUS during the forecast period.
Market players adopt various strategies to increase the reach of their products and improve availability in diverse geographic areas. In July 2023, UroMems announced that it had completed the first-ever implant of the “UroActive Smart” automated AUS in a female patient with SUI. This device is powered by a MyoElectroMechanical System (MEMS). Thus, introducing a technologically advanced AUS is expected to boost market growth. Moreover, major players are undertaking various initiatives, such as mergers & acquisitions of small firms, to strengthen their product portfolio. For instance, in August 2020, Creo Medical Group acquired Albyn Medical, a manufacturer of urology, endoscopy, and gastroenterology products, for USD 27.43. This acquisition improved Creo Medical’s extensive worldwide sales, logistics, service, production, and export capability, driving the market growth.
Request a free sample copy or view report summary: Artificial Urinary Sphincter Market Report
In 2022, the AMS 800 segment dominated the market with a market share of 85.25%. This dominance can be attributed to the growing use of the device to prevent urine incontinence
In 2022, the male segment dominated the market with a share of 87.56% due to increased awareness about the importance of AUS in preventing urinary leakages
North America held the largest revenue share of 42.81% in 2022 due to technological advancements and high investment by the government to support the adoption of advanced AUS devices
The global market is highly competitive and is characterized by the presence of several global as well as regional companies
Grand View Research has segmented the global artificial urinary sphincter market on the basis of brand, end-user, and region:
Artificial Urinary Sphincter Brand Outlook (Revenue, USD Million, 2018 - 2030)
AMS 800
Others
Artificial Urinary Sphincter End-user Outlook (Revenue, USD Million, 2018 - 2030)
Male
Female
Artificial Urinary Sphincter Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Artificial Urinary Sphincter Market
Boston Scientific Corporation
Creo Medical Ltd.
Zephyr Surgical Implants
Rules-Based Medicine
GT Urological (GTU)
"The quality of research they have done for us has been excellent..."